Sudo, M., Li, Y., Hiro, T., Takayama, T., Mitsumata, M., Shiomi, M., . . . Hirayama, A. (2017). Inhibition of plaque progression and promotion of plaque stability by glucagon-like peptide-1 receptor agonist: Serial in vivo findings from iMap-IVUS in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis, 265, 283-291. https://doi.org/10.1016/j.atherosclerosis.2017.06.920
Chicago-Zitierstil (17. Ausg.)Sudo, Mitsumasa, et al. "Inhibition of Plaque Progression and Promotion of Plaque Stability by Glucagon-like Peptide-1 Receptor Agonist: Serial In vivo Findings from IMap-IVUS in Watanabe Heritable Hyperlipidemic Rabbits." Atherosclerosis 265 (2017): 283-291. https://doi.org/10.1016/j.atherosclerosis.2017.06.920.
MLA-Zitierstil (9. Ausg.)Sudo, Mitsumasa, et al. "Inhibition of Plaque Progression and Promotion of Plaque Stability by Glucagon-like Peptide-1 Receptor Agonist: Serial In vivo Findings from IMap-IVUS in Watanabe Heritable Hyperlipidemic Rabbits." Atherosclerosis, vol. 265, 2017, pp. 283-291, https://doi.org/10.1016/j.atherosclerosis.2017.06.920.